USE OF SODIUM IPODATE IN MANAGEMENT OF HYPERTHYROIDISM IN SUBACUTE THYROIDITIS

Five hyperthyroid patients (two men and three women) with typical Feat ures of subacute thyroiditis were treated with sodium ipodate (Oragraf in; 0.5 g, orally daily or every other day) for 15-60 days; the treatm ent was stopped when both serum T-4 and T-3 levels were normal. All pa tients studied demonstrated a prompt normalization of serum T-3, impro vement in clinical symptoms of hyperthyroidism, and/or weight gain. We observed no side-effects of treatment with sodium ipodate. Our data s uggest that sodium ipodate is a safe and effective. agent for manageme nt of hyperthyroidism in subacute thyroiditis.